TherapeuticsMD, Inc. Debt Instrument, Face Amount
TherapeuticsMD, Inc. (TXMD) had Debt Instrument, Face Amount of $75.00 million as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2019-05-08
- 2019-03-31: Debt Instrument, Face Amount $75.00M.
- 2018-12-31: Debt Instrument, Face Amount $75.00M.
- 2018-09-30: Debt Instrument, Face Amount $75.00M.
- 2018-06-30: Debt Instrument, Face Amount $75.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2019-03-31 | $75.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $75.00M 10-Q · filed 2019-05-08 |
| 2018-09-30 | $75.00M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $75.00M 10-Q · filed 2018-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |